Muniz Juliana, Gonçalves Neto Antonio O, Morais Beatriz A A H, Suciu-Bogdan Camil, Ferreira David, Braghiroli Joao, Camara Sergio F, Ribeiro Henrique B
Internal Medicine Department, Schmieder Klinik Heidelberg, Heidelberg, Germany.
Federal University of Paraná, Curitiba, Brazil.
Catheter Cardiovasc Interv. 2025 Apr 27. doi: 10.1002/ccd.31547.
Current guidelines recommend routine fasting before cardiac catheterization under conscious sedation. However, data supporting this practice have been limited.
We aimed to compare the safety and patient well-being of a non-fasting strategy to standard fasting in patients who undergo heart catheterization procedures.
We conducted a meta-analysis of randomized studies comparing fasting versus non-fasting before cardiac catheterization. We systematically reviewed PubMed, Embase, and Cochrane databases until October 2024. We incorporated unpublished subgroup data from the previously published SCOFF Trial, exclusively on patients who underwent catheterization procedures.
We included 7 RCTs comprising 3289 patients who underwent cardiac catheterization procedures. The pooled analysis demonstrated the non-inferiority of the non-fasting strategy, with no significant differences in the incidences of nausea/vomiting (RR 0.90; 95% CI 0.50-1.61; p = 0.72), hypoglycemia (RR 0.78; 95% CI 0.45-1.35, p = 0.38), acute kidney injury (RR 1.45; 95% CI 0.77-2.75, p = 0.251), and length of hospital stay (SMD 0.005, 95% CI -0.109 to 0.099, p = 0.92) compared to the fasting strategy. The non-fasting strategy was significantly associated with reduced rates of intraprocedural hypotension and showed a statistically significant improvement in overall patient satisfaction (SMD -0.749; 95% CI -1.26; -0.234, p = 0.004) when compared to the fasting strategy.
A non-fasting strategy before cardiac catheterization procedures is as safe as the standard fasting protocol and demonstrates a significant improvement of overall patient satisfaction. These findings support the consideration of non-fasting protocols as a patient-centered approach that maintains safety while enhancing the patient experience.
当前指南建议在清醒镇静下进行心导管插入术前常规禁食。然而,支持这种做法的数据有限。
我们旨在比较非禁食策略与标准禁食对接受心脏导管插入术患者的安全性和患者舒适度。
我们对比较心导管插入术前禁食与非禁食的随机研究进行了荟萃分析。我们系统检索了截至2024年10月的PubMed、Embase和Cochrane数据库。我们纳入了先前发表的SCOFF试验中未发表的亚组数据,该试验专门针对接受导管插入术的患者。
我们纳入了7项随机对照试验,共3289例接受心脏导管插入术的患者。汇总分析表明非禁食策略不劣于禁食策略,与禁食策略相比,恶心/呕吐发生率(相对风险0.90;95%置信区间0.50-1.61;p = 0.72)、低血糖发生率(相对风险0.78;95%置信区间0.45-1.35,p = 0.38)、急性肾损伤发生率(相对风险1.45;95%置信区间0.77-2.75,p = 0.251)和住院时间(标准化均数差0.005,95%置信区间-0.109至0.099,p = 0.92)均无显著差异。与禁食策略相比,非禁食策略与术中低血压发生率降低显著相关,且总体患者满意度有统计学显著改善(标准化均数差-0.749;95%置信区间-1.26;-0.234,p = 0.004)。
心脏导管插入术前的非禁食策略与标准禁食方案一样安全,且总体患者满意度有显著提高。这些发现支持将非禁食方案作为一种以患者为中心的方法加以考虑,该方法在维持安全性的同时提升患者体验。